Friday, April 13, 2018

IMPRIMIS PHARMACEUTICALS, INC. (NASDAQ:IMMY) Files An 8 ...

Market Exclusive-7 hours ago
Imprimis Pharmaceuticals, Inc. (Imprimis) is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drugtherapies and providing such therapies through sterile and non-sterile pharmaceutical compoundingservices segment.
Post a Comment